Abstract

HIV has been reported to be cytotoxic in vitro and in lymph node infection models. Using a computational approach, we found that partial inhibition of transmissions of multiple virions per cell could lead to increased numbers of live infected cells. If the number of viral DNA copies remains above one after inhibition, then eliminating the surplus viral copies reduces cell death. Using a cell line, we observed increased numbers of live infected cells when infection was partially inhibited with the antiretroviral efavirenz or neutralizing antibody. We then used efavirenz at concentrations reported in lymph nodes to inhibit lymph node infection by partially resistant HIV mutants. We observed more live infected lymph node cells, but with fewer HIV DNA copies per cell, relative to no drug. Hence, counterintuitively, limited attenuation of HIV transmission per cell may increase live infected cell numbers in environments where the force of infection is high.

Article and author information

Author details

  1. Laurelle Jackson

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  2. Jessica Hunter

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  3. Sandile Cele

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  4. Isabella Markham Ferreira

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  5. Andrew C Young

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3616-7956
  6. Farina Karim

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  7. Rajhmun Madansein

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  8. Kaylesh J Dullabh

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  9. Chih-Yuan Chen

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  10. Noel J Buckels

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  11. Yashica Ganga

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  12. Khadija Khan

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  13. Mikael Boulle

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  14. Gila Lustig

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  15. Richard A Neher

    Biozentrum, University of Basel, Basel, Switzerland
    Competing interests
    Richard A Neher, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2525-1407
  16. Alex Sigal

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    For correspondence
    alex.sigal@k-rith.org
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8571-2004

Funding

Human Frontier Science Program (CDA 00050/2013)

  • Alex Sigal

European Research Council (Stg. 260686)

  • Richard A Neher

DELTAS Africa Initiative (Graduate Fellowship)

  • Isabella Markham Ferreira

National Research Foundation (Graduate Fellowship)

  • Laurelle Jackson

National Institutes of Health (R21MH104220)

  • Alex Sigal

National Research Foundation (Graduate Fellowship)

  • Jessica Hunter

Poliomyelitis Research Foundation (Graduate Fellowship)

  • Isabella Markham Ferreira

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Lymph nodes were obtained from the field of surgery of participants undergoing surgery for diagnostic purposes and/or complications of inflammatory lung disease. Informed consent was obtained from each participant, and the study protocol approved by the University of KwaZulu-Natal Institutional Review Board (approval BE024/09).

Copyright

© 2018, Jackson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,691
    views
  • 218
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Laurelle Jackson
  2. Jessica Hunter
  3. Sandile Cele
  4. Isabella Markham Ferreira
  5. Andrew C Young
  6. Farina Karim
  7. Rajhmun Madansein
  8. Kaylesh J Dullabh
  9. Chih-Yuan Chen
  10. Noel J Buckels
  11. Yashica Ganga
  12. Khadija Khan
  13. Mikael Boulle
  14. Gila Lustig
  15. Richard A Neher
  16. Alex Sigal
(2018)
Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death
eLife 7:e30134.
https://doi.org/10.7554/eLife.30134

Share this article

https://doi.org/10.7554/eLife.30134

Further reading

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    A Sofia F Oliveira, Fiona L Kearns ... Adrian J Mulholland
    Short Report

    The spike protein is essential to the SARS-CoV-2 virus life cycle, facilitating virus entry and mediating viral-host membrane fusion. The spike contains a fatty acid (FA) binding site between every two neighbouring receptor-binding domains. This site is coupled to key regions in the protein, but the impact of glycans on these allosteric effects has not been investigated. Using dynamical nonequilibrium molecular dynamics (D-NEMD) simulations, we explore the allosteric effects of the FA site in the fully glycosylated spike of the SARS-CoV-2 ancestral variant. Our results identify the allosteric networks connecting the FA site to functionally important regions in the protein, including the receptor-binding motif, an antigenic supersite in the N-terminal domain, the fusion peptide region, and another allosteric site known to bind heme and biliverdin. The networks identified here highlight the complexity of the allosteric modulation in this protein and reveal a striking and unexpected link between different allosteric sites. Comparison of the FA site connections from D-NEMD in the glycosylated and non-glycosylated spike revealed that glycans do not qualitatively change the internal allosteric pathways but can facilitate the transmission of the structural changes within and between subunits.

    1. Computational and Systems Biology
    George N Bendzunas, Dominic P Byrne ... Natarajan Kannan
    Research Article

    In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.